{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:44:38Z","timestamp":1783007078187,"version":"3.54.5"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81973743"],"award-info":[{"award-number":["81973743"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Chronic gastritis (CG), as the highest incidence of gastrointestinal diseases, has been gradually increasing around globally. With the obvious disadvantages of standard treatment, more and more people ask the traditional Chinese medicine for help in the treatment of CG. As a traditional Chinese medicine compound, Zuojin Pill (ZJP) has a long history of clinical application in the treatment of digestive system diseases. Whereas, neither systematic nor meta-analysis of randomized controlled trials explain the efficacy and safety of ZJP in treating CG. Thus, we provide a protocol to evaluate the efficacy and safety of ZJP for CG.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>From the beginning to December 2019, the following electronic databases will be searched for studies in English or Chinese: the Cochrane Library, Embase, PubMed, Web of Science, the Chinese National Knowledge Infrastructure, the Chinese Biomedical Literature Database, the Chinese Scientific Journal Database, and the Wanfang Database. Clinical efficiency, helicobacter pylori infection clearance rate, quality of life and symptom scores will be measured as primary outcomes. Meta-analysis will be performed using the Stata 15.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>This study will provide the current evidence of CG treated with ZJP from the several aspects including clinical efficiency, helicobacter pylori infection clearance rate, quality of life, symptom scores, the 1-year recurrent rate, efficacy under endoscopy and number of reported adverse events associated with the use of ZJP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The outcomes of this review will be served as a proof to evaluate if ZJP is effective in the treatment of CG.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PROSPERO registration number:<\/jats:title>\n            <jats:p>PROSPERO CRD42020155036.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021248","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T18:03:45Z","timestamp":1595009025000},"page":"e21248","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and safety of Zuojin Pill for chronic gastritis"],"prefix":"10.1097","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8590-4898","authenticated-orcid":false,"given":"Jianglong","family":"Shi","sequence":"first","affiliation":[{"name":"School of Basic Medicine Sciences, Chengdu University of Traditional Chinese Medicine , Chengdu, Sichuan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Basic Medicine Sciences, Chengdu University of Traditional Chinese Medicine , Chengdu, Sichuan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Sports Medicine, Shanghai University of Sport, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoju","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Basic Medicine Sciences, Chengdu University of Traditional Chinese Medicine , Chengdu, Sichuan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Qiu","sequence":"additional","affiliation":[{"name":"School of Basic Medicine Sciences, Chengdu University of Traditional Chinese Medicine , Chengdu, Sichuan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3109\/00365521.2015.1019918","article-title":"Chronic gastritis","volume":"50","author":"Sipponen","year":"2015","journal-title":"Scand J Gastroenterol"},{"issue":"(Suppl 1)","key":"R2-20230915","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1440-1746.2010.06536.x","article-title":"The Sydney System for classification of gastritis 20 years ago","volume":"26","author":"Sipponen","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.semdp.2014.02.008","article-title":"Pathology and differential diagnosis of chronic, noninfectious gastritis","volume":"31","author":"Polydorides","year":"2014","journal-title":"Semin Diagn Pathol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/1751-2980.12593","article-title":"Chinese consensus on chronic gastritis (2017, Shanghai)","volume":"19","author":"Fang","year":"2018","journal-title":"J Dig Dis"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-230X-14-21","article-title":"Chronic gastritis in China: a national multi-center survey","volume":"14","author":"Du","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/5584_2019_360","article-title":"Immune cell signaling by Helicobacter pylori: impact on gastric pathology","volume":"1149","author":"Blaser","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1590\/S0102-67202012000200007","article-title":"Factors associated with chronic gastritis in patients with presence and absence of Helicobacter pylori","volume":"25","author":"Ddine","year":"2012","journal-title":"Arq Bras Cir Dig"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41419-018-0982-2","article-title":"Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract","volume":"9","author":"Yu","year":"2018","journal-title":"Cell Death Dis"},{"key":"R9-20230915","first-page":"27","article-title":"Human and Helicobacter pylori interactions determine the outcome of gastric diseases","volume":"400","author":"Gobert","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"e13150","DOI":"10.1111\/eci.13150","article-title":"Helicobacter pylori pathogenicity and primary antimicrobial resistance in Northern Spain","volume":"49","author":"Fern\u00e1ndez-Reyes","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"R11-20230915","first-page":"88","article-title":"How to measure (or not) compliance to eradication therapy","volume":"4","author":"Martins","year":"2006","journal-title":"Pharm Pract (Granada)"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/1040841X.2017.1418285","article-title":"Resistance mechanisms of Helicobacter pylori and its dual target precise therapy","volume":"44","author":"Gong","year":"2018","journal-title":"Crit Rev Microbiol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.3748\/wjg.v21.i48.13432","article-title":"High antibiotic resistance rate: a difficult issue for Helicobacter pylori eradication treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"e22339","DOI":"10.1002\/jcla.22339","article-title":"Antibiotic resistance of Helicobacter pylori to 16 antibiotics in clinical patients","volume":"32","author":"Shao","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jgar.2018.03.005","article-title":"Helicobacter pylori therapy and clinical perspective","volume":"14","author":"Talebi Bezmin Abadi","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5114\/aoms.2016.58595","article-title":"Comparison of the efficacy and safety of hybrid and sequential therapies as a first-line regimen for Helicobacter pylori infection in Turkey","volume":"14","author":"Kefeli","year":"2018","journal-title":"Arch Med Sci"},{"key":"R17-20230915","first-page":"462","article-title":"The patients\u2019 adherence and adverse drug reactions (ADRs) which are Caused by Helicobacter pylori eradication regimens","volume":"7","author":"Abbasinazari","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"R18-20230915","first-page":"429","article-title":"Helicobacter Pylori infection","volume":"115","author":"Fischbach","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3109\/00365529409092468","article-title":"Risk of recurrence of gastric ulcer, chronic gastritis, and grade of Helicobacter pylori colonization. A long-term follow-up study of 25 patients","volume":"29","author":"Maaroos","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3892\/mco.2012.22","article-title":"Elevated risk of recurrent colorectal neoplasia with Helicobacter pylori-associated chronic atrophic gastritis: a follow-up study of patients with endoscopically resected colorectal neoplasia","volume":"1","author":"Inoue","year":"2013","journal-title":"Mol Clin Oncol"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1111\/jocn.14114","article-title":"The relationship of interpersonal sensitivity and depression among patients with chronic atrophic gastritis: the mediating role of coping styles","volume":"27","author":"Zhao","year":"2018","journal-title":"J Clin Nurs"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/13548506.2018.1428756","article-title":"Psychological distress in patients with chronic atrophic gastritis: the risk factors, protection factors, and cumulative effect","volume":"23","author":"Sun","year":"2018","journal-title":"Psychol Health Med"},{"key":"R23-20230915","first-page":"32","article-title":"Quality of life and attitude to the disease in patients with chronic gastritis","volume":"80","author":"Dzhula\u012d","year":"2002","journal-title":"Klin Med (Mosk)"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/apt.14319","article-title":"Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori","volume":"46","author":"Hu","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"e15710","DOI":"10.1097\/MD.0000000000015710","article-title":"Efficacy of traditional Chinese medicine for chronic gastritis: a meta-analysis of randomized controlled trials","volume":"98","author":"Yan","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R26-20230915","first-page":"6151","article-title":"Protective effects of alginate-chitosan microspheres loaded with alkaloids from Coptis chinensis Franch. and Evodia rutaecarpa (Juss.) Benth. (Zuojin Pill) against ethanol-induced acute gastric mucosal injury in rats","volume":"9","author":"Wang","year":"2015","journal-title":"Drug Des Devel Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:31:42Z","timestamp":1694827902000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021248"}},"subtitle":["Protocol for a systematic review of randomized controlled trials"],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":26,"journal-issue":{"issue":"29","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021248","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]}}}